Tolebrutinib meets primary endpoint in HERCULES phase 3 study
Phase 3 study results will form the basis for future discussions with global regulatory authorities
Phase 3 study results will form the basis for future discussions with global regulatory authorities
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
The hospital in association with ‘We Warriors’ and ‘Dev Bhumi Rakshak Foundation’ organized First Aid and CPR training session for youngsters and volunteers
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
These initiatives aim to improve access to healthcare for rare disease patients
The company has also been named among global sustainability leaders for the 7th year in a row in the Dow Jones Sustainability Index in the Emerging Markets category
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
Ayúdame3D has become a leading social entity in social technology.
Subscribe To Our Newsletter & Stay Updated